Edition:
United States

Brendan Pierson

Takeda loses bid to narrow pay-for-delay case ahead of trial

Nov 27 2020

Takeda Pharmaceutical has lost a bid to limit claims in a case accusing its predecessor Shire Plc of conspiring with generic rival Actavis to delay launch of a generic version of Shire's ADHD drug Intuniv through illegal patent settlements.

Preview: 2nd Circuit to weigh fate of Mirena MDL

Nov 27 2020

The 2nd U.S. Circuit Court of Appeals is expected to hear arguments next week over whether to revive more than 900 lawsuits by women who said they developed a rare neurological condition after using Bayer AG's Mirena contraceptive device.

Judge calls Gilead's defense aggressive, threatens fees in books and records request

Nov 24 2020

A group of investors can examine Gilead Science Inc's books and records for evidence of misconduct related to the marketing of one of its leading HIV drugs, a Delaware judge has ruled, castigating the company's "overly aggressive" defense and suggesting it could be required to pay the investors' fees.

Utah biotech company wins dismissal of shareholder lawsuit

Nov 23 2020

A federal judge has dismissed a shareholder lawsuit accusing Salt Lake City, Utah-based biotech company PolarityTE Inc of misleading investors about the prospects of its regenerative skin tissue product.

Pfizer generic epinephrine shot would infringe Endo patents - Fed Circuit

Nov 23 2020

Pfizer Inc unit Hospira's proposed generic version of Endo International PLC's emergency allergy treatment Adrenalin would infringe two of Endo's patents, a federal appeals court has ruled, affirming a lower court ruling blocking the generic drug from the market.

Ex-Akebia, Merrimack employees' insider trading convictions stand

Nov 20 2020

The 1st U.S. Circuit Court of Appeals on Friday upheld the convictions and prison sentences of former Akebia Therapeutics Inc and Merrimack Pharmaceuticals Inc employees who were found to have taken part in an insider trading scheme.

Judge rebuffs Merck's renewed bid to arbitrate vaccine antitrust cases

Nov 20 2020

A lawsuit accusing Merck & Co Inc of illegally stifling competition for its rotavirus vaccine RotaTeq can proceed as a class action, a Philadelphia federal judge has ruled, rejecting the drugmaker's bid to send the case to arbitration a second time after being directed by a U.S. appeals court to reconsider the issue.

Theranos documents not privileged, prosecutors say

Nov 20 2020

Federal prosecutors have asked a judge to rule that Theranos Inc founder Elizabeth Holmes and former chief operating officer Ramesh "Sunny" Balwani cannot assert privilege over Theranos' corporate documents in their criminal fraud case.

Tofurky maker urges court to block Missouri law on faux meat marketing

Nov 19 2020

The maker of Tofurky meat substitute on Thursday urged a federal appeals court to strike down a Missouri law making it a crime to misrepresent a plant-based product as a meat product, one of several similar state laws the company is fighting around the country.

Vectura's $89.7 mln inhaler patent win against GSK upheld

Nov 19 2020

GlaxoSmithKline PLC has lost an appeal seeking to overturn an $89.7 million verdict a jury handed down after finding that the company's Ellipta line of inhalers infringed a patent belonging to rival drug company Vectura Ltd.

World News